TVTX

Travere Therapeutics, Inc.

NasdaqGM · Healthcare

$58.47

+0.19% today

last filing 2026-06-22Pro sees filings in ~15 min

Price

hover · 4 moves explained

40 sells

Analyst consensus

Strong Buy

$58.36target-0.2%vs $58.47 today

$43.00 low today target$70.00 high

14 analysts · ~12-month consensus · as of Jul 7. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25

$0.13

exp $0.04

Q3 '25

$0.59

exp −$0.09

Q4 '25-0.8%

$0.37

exp $0.37

Q1 '26

$0.05

exp −$0.06

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Gift	2026-06-22	Inrig Jula	CHIEF MEDICAL OFFICER	—Direct	468	—	—
Grant	2026-05-21	Williams Brinkley Ruth	Director	—Direct	4,000	—	—
Grant	2026-05-21	Squarer Ron	Director	—Direct	4,000	—	—
Grant	2026-05-21	Poole Sandra	Director	—Direct	4,000	—	—
Grant	2026-05-21	Orwin John A	Director	—Direct	4,000	—	—

Gift

Inrig Jula

CHIEF MEDICAL OFFICER · 2026-06-22

—

468 shares

Grant

Williams Brinkley Ruth

Director · 2026-05-21

—

4,000 shares

Grant

Squarer Ron

Director · 2026-05-21

—

4,000 shares

Grant

Poole Sandra

Director · 2026-05-21

—

4,000 shares

Grant

Orwin John A

Director · 2026-05-21

—

4,000 shares

72 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →